Exact Sciences Balance Sheet Health
Financial Health criteria checks 4/6
Exact Sciences has a total shareholder equity of $3.1B and total debt of $2.4B, which brings its debt-to-equity ratio to 75.2%. Its total assets and total liabilities are $6.5B and $3.3B respectively.
Key information
75.2%
Debt to equity ratio
US$2.36b
Debt
Interest coverage ratio | n/a |
Cash | US$777.64m |
Equity | US$3.15b |
Total liabilities | US$3.33b |
Total assets | US$6.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: E2XA34's short term assets ($1.2B) exceed its short term liabilities ($514.7M).
Long Term Liabilities: E2XA34's short term assets ($1.2B) do not cover its long term liabilities ($2.8B).
Debt to Equity History and Analysis
Debt Level: E2XA34's net debt to equity ratio (50.4%) is considered high.
Reducing Debt: E2XA34's debt to equity ratio has reduced from 101.8% to 75.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable E2XA34 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: E2XA34 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 0% per year.